166 related articles for article (PubMed ID: 25788956)
21. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
[TBL] [Abstract][Full Text] [Related]
23. Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients.
Jansen L; Welkers MRA; van Dort KA; Takkenberg RB; Lopatin U; Zaaijer HL; de Jong MD; Reesink HW; Kootstra NA
Antiviral Res; 2017 Sep; 145():87-95. PubMed ID: 28754258
[TBL] [Abstract][Full Text] [Related]
24. Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations.
Agarwal AK; Sen S; Banerjee D; Srivastava R; Praharaj AK
Med J Armed Forces India; 2015 Jul; 71(3):225-32. PubMed ID: 26288490
[TBL] [Abstract][Full Text] [Related]
25. High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
Castelain S; Descamps V; Brochot E; Helle F; Duverlie G; Nguyen-Khac E; François C
Arch Virol; 2017 Jul; 162(7):1913-1920. PubMed ID: 28289975
[TBL] [Abstract][Full Text] [Related]
26. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
27. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Lapalus M; Laouenan C; Cardoso AC; Estrabaud E; Carvalho-Filho RJ; Zhang Q; Lada O; Appourchaux K; Mouri F; Boyer N; Bedossa P; Asselah T; Martinot-Peignoux M; Marcellin P
Liver Int; 2015 Sep; 35(9):2082-9. PubMed ID: 25612083
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
29. Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case-control study.
Farshadpour F; Taherkhani R; Saberi F
BMC Infect Dis; 2022 Jun; 22(1):553. PubMed ID: 35715756
[TBL] [Abstract][Full Text] [Related]
30. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
Belyhun Y; Liebert UG; Maier M
PLoS One; 2018; 13(2):e0191970. PubMed ID: 29408943
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of mutations in basal core promoter and precore region of hepatitis B virus in vaccinated and nonvaccinated individuals of the aboriginal Nicobarese tribe of Car Nicobar Island, India.
Bhattacharya H; Bhattacharya D; Nagarajan M; Reesu R; Roy S; Attayur PS
Intervirology; 2014; 57(6):357-64. PubMed ID: 25323975
[TBL] [Abstract][Full Text] [Related]
32. [Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels].
Yang YH; Xie Q; Wang H; Zhou HJ; Gui HL; Cai W; Guo SM; Yu H; Guo Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):434-9. PubMed ID: 19567022
[TBL] [Abstract][Full Text] [Related]
33. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
34. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
[TBL] [Abstract][Full Text] [Related]
35. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
36. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
[TBL] [Abstract][Full Text] [Related]
37. Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.
Chuaypen N; Payungporn S; Poovorawan K; Chotiyaputta W; Piratvisuth T; Tangkijvanich P
Virus Genes; 2019 Oct; 55(5):610-618. PubMed ID: 31359359
[TBL] [Abstract][Full Text] [Related]
38. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
Tacke F; Gehrke C; Luedde T; Heim A; Manns MP; Trautwein C
J Virol; 2004 Aug; 78(16):8524-35. PubMed ID: 15280461
[TBL] [Abstract][Full Text] [Related]
39. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.
Yoo BC; Park JW; Kim HJ; Lee DH; Cha YJ; Park SM
J Hepatol; 2003 Jan; 38(1):98-103. PubMed ID: 12480566
[TBL] [Abstract][Full Text] [Related]
40. Correlation Between Hepatitis B G1896A Precore Mutations and HBeAg in Chronic HBV Patients.
Zhand S; Karami C; Hosseinzadeh Adli A; Tabarraei A; Khodabakhshi B; Moradi A
Jundishapur J Microbiol; 2015 Feb; 8(2):e17126. PubMed ID: 25825644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
